ANDA
Andina Acquisition Corp. III
stock NASDAQ

Does anyone follow ANDA approval status of NRxP's Ketafree

https://preview.redd.it/joylw40r6yfh1.png?width=692&format=png&auto=webp&s=b62b4583eba14cf61d6a6daa1db5d5aba9eefe73
Let's be honest...if you've seen any of my posts on this stock, you know how much I believe in it, but there is no denying that the last year has been rough for the share price. I think we can also be honest about something else though - I probably study this stock more than almost any other person on these subs or other boards, and, so, I thought I would share a pattern I've noticed. I went back 5 years and noticed a dead on trend that happens every single year. MASSIVE volume increases from July to August, that usually ends in large spikes in price through September to November (depending on news releases etc.).
**AVERAGE volume increase from July to August - 151%**
**AVERAGE price increase from July to August - 69%**
This is a company that has increased revenue every single year for 5 or 6 years now - 5000% increase in revs over that time. Just filed an ANDA for a $27 Billion drug and they have a 100% approval history on ANDAs. Just settled litigation with Purdue Pharma so there is a clear path to file for generic Oxy in 2027. Just received positive BE results on another generic drug with an ANDA to follow. Actively in discussions with a potential buyer, and IF no buyer comes to the table with an agreeable price, the CFO has spent the last few years prepping for the company to uplist to the Nasdaq. CEO wrapped up the last earnings call a few weeks ago stating that they company had outgrown the OTC and that they are ready to uplist.
Cheers to the longs! See you at the finish line.

Does anyone follow ANDA approval status of NRxP's Ketafree

https://preview.redd.it/joylw40r6yfh1.png?width=692&format=png&auto=webp&s=b62b4583eba14cf61d6a6daa1db5d5aba9eefe73
Let's be honest...if you've seen any of my posts on this stock, you know how much I believe in it, but there is no denying that the last year has been rough for the share price. I think we can also be honest about something else though - I probably study this stock more than almost any other person on these subs or other boards, and, so, I thought I would share a pattern I've noticed. I went back 5 years and noticed a dead on trend that happens every single year. MASSIVE volume increases from July to August, that usually ends in large spikes in price through September to November (depending on news releases etc.).
**AVERAGE volume increase from July to August - 151%**
**AVERAGE price increase from July to August - 69%**
This is a company that has increased revenue every single year for 5 or 6 years now - 5000% increase in revs over that time. Just filed an ANDA for a $27 Billion drug and they have a 100% approval history on ANDAs. Just settled litigation with Purdue Pharma so there is a clear path to file for generic Oxy in 2027. Just received positive BE results on another generic drug with an ANDA to follow. Actively in discussions with a potential buyer, and IF no buyer comes to the table with an agreeable price, the CFO has spent the last few years prepping for the company to uplist to the Nasdaq. CEO wrapped up the last earnings call a few weeks ago stating that they company had outgrown the OTC and that they are ready to uplist.
Cheers to the longs! See you at the finish line.